柏树
发表于 2025-3-23 18:45:09
Pharmacological Treatment Options for Levodopa-Induced Dyskinesia,lude the antiglutamatergic drug amantadine and the antipsychotic clozapine (which carries a risk of leukopenia and requires regular blood checks)..In patients with motor complications refractory to all adjustments of oral and transdermal treatments and where deep brain stimulation is either contrain
Macronutrients
发表于 2025-3-23 23:48:12
http://reply.papertrans.cn/59/5855/585422/585422_14.png
alliance
发表于 2025-3-24 02:23:18
Pharmacological Properties of Levodopa, which is thought to be a key determinant underlying the dyskinetic state. Therapeutic approaches that would produce continuous drug delivery (CDD) and ensuing continuous dopaminergic stimulation (CDS) have been actively sought. After a brief historical review, this chapter summarizes the biochemica
排出
发表于 2025-3-24 07:27:59
http://reply.papertrans.cn/59/5855/585422/585422_16.png
保守党
发表于 2025-3-24 11:03:39
http://reply.papertrans.cn/59/5855/585422/585422_17.png
男学院
发表于 2025-3-24 16:24:08
Involvement of the Cholinergic System in Levodopa-Induced Dyskinesia, acting at nAChRs, with the α4β2, α6β2, and α7 receptor subtypes all contributing to the occurrence of LID. An involvement of multiple subtypes in LID is also supported by studies with drugs targeting select nAChR populations. Notably, nicotine and nAChR drugs did not worsen parkinsonism in any anim
blackout
发表于 2025-3-24 19:32:29
New Clinical Trials for Levodopa-Induced Dyskinesia,odopa-sparing agents on LID is also being investigated, both in early and advanced PD. Moreover, non-dopaminergic agents are being studied as add-on therapies in established LID. Such agents are also being studied in early PD, either as monotherapy to improve parkinsonian symptoms without causing dy
流行
发表于 2025-3-25 02:43:52
ced Dyskinesia in Parkinson’s Disease. is aimed at an international audience of movement disorder neurologists; neuroscientists; trainees and graduate and post-graduate students..978-1-4471-7238-3978-1-4471-6503-3
混合物
发表于 2025-3-25 06:23:42
Elisabetta Tronci,Camino Fidalgo,Manolo Cartan anschließend wird der Versuch unternommen, Interessen in ihrem multidimensionalen und prozesshaften Charakter als „Interessierung“ neu zu fassen und in ihren Implikationen für Th978-3-658-33726-1978-3-658-33727-8
MITE
发表于 2025-3-25 11:08:36
http://reply.papertrans.cn/59/5855/585422/585422_22.png